Role of radiotherapy in the treatment of metastatic head and neck cancer

: In metastatic or locally advanced head and neck tumors that present in frail patients or after chemotherapy progression, radiotherapy is normally used as a palliative treatment, with a high rate of symptom palliation and improvement in quality of life. However, there is contro-versy about what the optimal regimen is. Moreover, despite the poor prognosis of metastatic head and neck cancer, different retrospective studies have shown that a minority of patients with oligometastatic disease experience prolonged disease-free survival after adding curative radiotherapy treatment to the metastatic disease and/or primary tumor. Different retrospective studies have identified clinical prognostic factors that may be used to select candidate patients with metastatic head and neck cancer for a radical approach with radiotherapy. The purpose of this manuscript is to review the role of radiotherapy in metastatic and locally advanced head and neck tumors.

[1]  U. Ricardi,et al.  Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach , 2016, Journal of radiation research.

[2]  A. Bujold,et al.  Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. , 2016, International journal of radiation oncology, biology, physics.

[3]  Peihong Wu,et al.  Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma. , 2016, Radiology.

[4]  R. Tishler,et al.  Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck. , 2015, Hematology/oncology clinics of North America.

[5]  R. Sun,et al.  Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival , 2015, Oncotarget.

[6]  E. Cohen,et al.  Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Mehanna,et al.  Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta‐analysis , 2015, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[8]  Ying Huang,et al.  Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors , 2014, PloS one.

[9]  J. Thariat,et al.  Local ablative treatments of oligometastases from head and neck carcinomas. , 2014, Critical reviews in oncology/hematology.

[10]  P. Busse,et al.  Long-term survival after distant metastasis in patients with oropharyngeal cancer. , 2014, Oral oncology.

[11]  John Wong,et al.  Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. , 2013, International journal of radiation oncology, biology, physics.

[12]  Oleksiy Karpenko,et al.  Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs , 2012, PloS one.

[13]  C. Belka,et al.  Dying cell clearance and its impact on the outcome of tumor radiotherapy , 2012, Front. Oncol..

[14]  R. Onimaru,et al.  Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence , 2012, Pulmonary medicine.

[15]  L. Dawson,et al.  Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[16]  E. Kunieda,et al.  Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Liru He,et al.  Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment? , 2011, Oral oncology.

[18]  N. Ikeda,et al.  Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas. , 2009, The Annals of thoracic surgery.

[19]  N. Kawashima,et al.  Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.

[20]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Okunieff,et al.  Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. , 2009, International journal of radiation oncology, biology, physics.

[22]  Masahiro Hiraoka,et al.  Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.

[23]  Robert D Timmerman,et al.  An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. , 2008, Seminars in radiation oncology.

[24]  P. Pai,et al.  Hypofractionated, palliative radiotherapy for advanced head and neck cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  C. Bokemeyer,et al.  Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.

[26]  B. Hickey,et al.  Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  M. Schell,et al.  Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.

[28]  R. Weichselbaum,et al.  Induced sensitization of tumor stroma leads to eradication of established cancer by T cells , 2007, The Journal of experimental medicine.

[29]  H. Willers,et al.  Introduction to clinical radiation biology. , 2006, Hematology/oncology clinics of North America.

[30]  L. Peters,et al.  The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  Samuel Ryu,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.

[32]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[33]  B. Mohanti,et al.  Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  K. Camphausen,et al.  Radiation abscopal antitumor effect is mediated through p53. , 2003, Cancer research.

[35]  C. Silver,et al.  Incidence and Sites of Distant Metastases from Head and Neck Cancer , 2001, ORL.

[36]  V. Rusch,et al.  Pulmonary Metastasectomy for Head and Neck Cancers , 1999, Annals of Surgical Oncology.

[37]  M. Nakamizo,et al.  Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck. , 1997, American journal of otolaryngology.

[38]  N. Petrelli,et al.  Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. , 1992, American journal of surgery.

[39]  R. Weichselbaum,et al.  The immunology of ablative radiation. , 2015, Seminars in radiation oncology.

[40]  D. Kallogjeri,et al.  Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. , 2014, Oral oncology.

[41]  Wei Xu,et al.  Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. , 2013, Oral oncology.

[42]  R. Weichselbaum,et al.  Oligometastases revisited , 2011, Nature Reviews Clinical Oncology.